SOPHARMA AD - Statement under Art. 32, para. 7 of the Law on the Introduction of the Euro in the Republic of Bulgaria (LIERB) regarding the initial public offering of an issue of warrants with an exercise period of up to 7 years

Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:

1. SFA_32_w7_09012025_espi.pdfStatement under Art. 32, para. 7 of the Law on the Introduction of the Euro in the Republic of Bulgaria (LIERB) regarding the initial public offering of an issue of warrants with an exercise period of up to 7 years
   

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 11 / 2026

Date of issue: 2026-01-09

Short name of the issuer

SOPHARMA AD

Subject

Statement under Art. 32, para. 7 of the Law on the Introduction of the Euro in the Republic of Bulgaria (LIERB) regarding the initial public offering of an issue of warrants with an exercise period of up to 7 years

Official market - legal basis

Art. 56. 1. 2 of Act on Public Offering

Unofficial market - legal basis

Contents of the report:

Sofia, Bulgaria, 9 January 2026 – “Sopharma” AD, with its registered office in Sofia, 16, Iliensko Shose Street, UIC831902088, LEI code 097900BGGW0000048796, pursuant to Art. 32, para. 7 of the LIERB, notifies all shareholders of the company and all interested parties that the introduction of the euro has no bearing on the valuation of the warrant issue with ISIN BG9200003259. The prospectus for the issue was approved by decision No. 769 - E of 16.12.2025 of the Financial Supervision Commission. All interested parties can familiarize themselves with the prospectus on the website of the FSC, on the website of “Sopharma” AD (www.sopharma.bg), on the website of the investment intermediary “Sofia International Securities“ AD (www.sis.bg) and on www.x3news.com.

Annexes

File Description

SFA_32_w7_09012025_espi.pdfSFA_32_w7_09012025_espi.pdf Statement under Art. 32, para. 7 of the Law on the Introduction of the Euro in the Republic of Bulgaria (LIERB) regarding the initial public offering of an issue of warrants with an exercise period of up to 7 years

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2026-01-09 Ognian Ivanov Donev Executive Director